123 related articles for article (PubMed ID: 20627731)
1. Matrix metalloproteinase-9 contributes to the increase of tau protein in serum during acute ischemic stroke.
Kurzepa J; Bielewicz J; Grabarska A; Stelmasiak Z; Stryjecka-Zimmer M; Bartosik-Psujek H
J Clin Neurosci; 2010 Aug; 17(8):997-9. PubMed ID: 20627731
[TBL] [Abstract][Full Text] [Related]
2. Effects of edaravone, a free radical scavenger, on serum levels of inflammatory biomarkers in acute brain infarction.
Isahaya K; Yamada K; Yamatoku M; Sakurai K; Takaishi S; Kato B; Hirayama T; Hasegawa Y
J Stroke Cerebrovasc Dis; 2012 Feb; 21(2):102-7. PubMed ID: 21215657
[TBL] [Abstract][Full Text] [Related]
3. Changes in plasma matrix metalloproteinase-9 levels in patients with acute ischemic stroke.
Cojocarui IM; Cojocaru M; Sapira V; Socoliuc G; Hertea C; Paveliu S
Rom J Intern Med; 2012; 50(2):155-8. PubMed ID: 23326959
[TBL] [Abstract][Full Text] [Related]
4. The temporal profile of inflammatory markers and mediators in blood after acute ischemic stroke differs depending on stroke outcome.
Worthmann H; Tryc AB; Goldbecker A; Ma YT; Tountopoulou A; Hahn A; Dengler R; Lichtinghagen R; Weissenborn K
Cerebrovasc Dis; 2010; 30(1):85-92. PubMed ID: 20484906
[TBL] [Abstract][Full Text] [Related]
5. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
Ylisirniö S; Höyhtyä M; Turpeenniemi-Hujanen T
Anticancer Res; 2000; 20(2B):1311-6. PubMed ID: 10810441
[TBL] [Abstract][Full Text] [Related]
6. [Correlation between the expression of proinflammatory cytokines and matrix metalloproteinases in the acute phase of an ischemic stroke].
Montaner J; Alvarez-Sabín J; Barberá G; Anglés A; Molina C; Abilleira S; Arenillas J; Chacón P; Monasterio J
Rev Neurol; 2001 Jul 16-31; 33(2):115-8. PubMed ID: 11562868
[TBL] [Abstract][Full Text] [Related]
7. Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke.
Ning M; Furie KL; Koroshetz WJ; Lee H; Barron M; Lederer M; Wang X; Zhu M; Sorensen AG; Lo EH; Kelly PJ
Neurology; 2006 May; 66(10):1550-5. PubMed ID: 16717217
[TBL] [Abstract][Full Text] [Related]
8. [Correlation between serum MMP-2 and MMP-9 in patients with acute myocardial infarction before and after PCI].
Dai F; Xiao GL; Pan J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Aug; 25(8):716-8. PubMed ID: 19664397
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of matrix metalloproteinase-2 and -9 in patients with head and neck squamous cell carcinoma.
Riedel F; Götte K; Schwalb J; Hörmann K
Anticancer Res; 2000; 20(5A):3045-9. PubMed ID: 11062721
[TBL] [Abstract][Full Text] [Related]
10. Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution.
Wu CY; Wu MS; Chiang EP; Chen YJ; Chen CJ; Chi NH; Shih YT; Chen GH; Lin JT
Clin Cancer Res; 2007 Apr; 13(7):2054-60. PubMed ID: 17404086
[TBL] [Abstract][Full Text] [Related]
11. High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma.
Nikkola J; Vihinen P; Vuoristo MS; Kellokumpu-Lehtinen P; Kähäri VM; Pyrhönen S
Clin Cancer Res; 2005 Jul; 11(14):5158-66. PubMed ID: 16033831
[TBL] [Abstract][Full Text] [Related]
12. [Zymography--method for quantitation of activity on gelatinase A (pro-MMP-2, 72 kDa) and gelatinase B (pro-MMP-9, 92 kDa) in serum of patients with breast cancer].
Sliwowska I; Kopczyński Z
Wiad Lek; 2007; 60(5-6):241-7. PubMed ID: 17966888
[TBL] [Abstract][Full Text] [Related]
13. Pre-ischemic exercise reduces matrix metalloproteinase-9 expression and ameliorates blood-brain barrier dysfunction in stroke.
Guo M; Cox B; Mahale S; Davis W; Carranza A; Hayes K; Sprague S; Jimenez D; Ding Y
Neuroscience; 2008 Jan; 151(2):340-51. PubMed ID: 18160227
[TBL] [Abstract][Full Text] [Related]
14. Temporal profile of molecular signatures associated with circulating endothelial progenitor cells in human ischemic stroke.
Sobrino T; Pérez-Mato M; Brea D; Rodríguez-Yáñez M; Blanco M; Castillo J
J Neurosci Res; 2012 Sep; 90(9):1788-93. PubMed ID: 22513751
[TBL] [Abstract][Full Text] [Related]
15. Effect of arundic acid on serum S-100beta in ischemic stroke.
Pettigrew LC; Kasner SE; Gorman M; Atkinson RP; Funakoshi Y; Ishibashi H;
J Neurol Sci; 2006 Dec; 251(1-2):57-61. PubMed ID: 17092520
[TBL] [Abstract][Full Text] [Related]
16. Neuron-specific enolase and tau protein as neurobiochemical markers of neuronal damage are related to early clinical course and long-term outcome in acute ischemic stroke.
Wunderlich MT; Lins H; Skalej M; Wallesch CW; Goertler M
Clin Neurol Neurosurg; 2006 Sep; 108(6):558-63. PubMed ID: 16457947
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of serum Matrix Metalloproteinase-9 in patients with moyamoya disease.
Fujimura M; Watanabe M; Narisawa A; Shimizu H; Tominaga T
Surg Neurol; 2009 Nov; 72(5):476-80; discussion 480. PubMed ID: 19147196
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.
Roldán V; Marín F; Gimeno JR; Ruiz-Espejo F; González J; Feliu E; García-Honrubia A; Saura D; de la Morena G; Valdés M; Vicente V
Am Heart J; 2008 Jul; 156(1):85-91. PubMed ID: 18585501
[TBL] [Abstract][Full Text] [Related]
19. Correlation between plasma levels of matrix metalloproteinase (MMP)-9 /MMP-2 ratio and alpha-fetoproteins in chronic hepatitis carrying hepatitis B virus.
Chung TW; Kim JR; Suh JI; Lee YC; Chang YC; Chung TH; Kim CH
J Gastroenterol Hepatol; 2004 May; 19(5):565-71. PubMed ID: 15086601
[TBL] [Abstract][Full Text] [Related]
20. Homocysteine and lipoprotein (a) correlation in ischemic stroke patients.
Dhamija RK; Gaba P; Arora S; Kaintura A; Kumar M; Bhattacharjee J
J Neurol Sci; 2009 Jun; 281(1-2):64-8. PubMed ID: 19285692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
